Bill119th CongressFiled May 29, 2026
H.R. 9077
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedMay 29, 2026
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Scholten, Hillary J. [D-MI-3](D-MI)Sponsor
1committees3actions